MedPath
NMPA Approval

Citicoline Injection

国药准字H20243523

April 17, 2024

Drug Information

胞磷胆碱注射液

注射剂

2ml∶0.25g(按C₁₄H₂₆N₄O₁₁P₂计)

化学药品

April 17, 2024

Company Information

Applicant Company

成都市温江区成都海峡两岸科技产业开发园柳台大道222号

Manufacturing Company

成都市海峡两岸科技产业开发园柳台大道222号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

胞磷胆碱注射液 - NMPA 批准文号 | MedPath